New Enterprise Associates 13, L.P. 13D and 13G filings for Sagimet Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-13 4:15 pm Sale |
2025-03-31 | 13G | Sagimet Biosciences Inc. SGMT |
New Enterprise Associates 13, L.P. | 0 0.000% |
-2,000,275 (Position Closed) |
Filing |
| 2024-02-14 6:10 pm Purchase |
2023-12-31 | 13G | Sagimet Biosciences Inc. SGMT |
New Enterprise Associates 13, L.P. | 2,000,275 6.600% |
2,000,275 (New Position) |
Filing |